Welcome to our dedicated page for Stratasys news (Ticker: SSYS), a resource for investors and traders seeking the latest updates and insights on Stratasys stock.
Stratasys Ltd. reports developments in polymer 3D printing and additive manufacturing for industrial, dental, medical and product-design applications. Company updates commonly cover connected 3D printers, polymer materials, GrabCAD software, parts on demand through Stratasys Direct, and platform families that include FDM, PolyJet, P3 DLP and SLA technologies.
Recurring news also includes quarterly and annual financial results, conference-call materials, product and material launches, application expansion in aerospace, automotive, consumer products, healthcare and defense, and regulatory milestones such as European certification for TrueDent dental resins. The company also announces Form 20-F availability and other public-company reporting matters as a Nasdaq-listed foreign issuer.
SolarEdge (Nasdaq: SEDG) appointed Maoz Sigron as Chief Financial Officer, effective May 31, 2026, succeeding Asaf Alperovitz, who departs for another opportunity and will stay through June 9, 2026 for transition.
Sigron brings 20+ years of global finance experience, including senior roles at Perion Network, Allot, Tnuva and Stratasys.
Stratasys (Nasdaq: SSYS) reported Q1 2026 revenue of $132.7M and GAAP net loss of $23.8M (−$0.28 per diluted share). Adjusted EBITDA was $2.0M with positive operating cash flow of $2.4M. Cash, equivalents and short-term deposits totaled $237.8M with no debt. The company reiterated full‑year 2026 guidance: revenue of $565M–$575M, non‑GAAP gross margin ~46.7%–47.1%, adjusted EBITDA $25M–$30M, non‑GAAP net income of $8M–$12.5M, and capex of $20M–$25M. Management cited adverse tariffs and FX headwinds factored into outlook.
Stratasys (NASDAQ: SSYS) won multiple industry awards at the 2026 RAPID + TCT conference and the AMGTA Member Summit on April 30, 2026. Key honors include a TCT Award in healthcare for an Eyelid Surgery Training Model developed with Addion and four AMGTA awards for sustainability under the Mindful Manufacturing™ framework.
The Eyelid Surgery Training Model is described as Europe’s first 3D-printed anatomical eye model for eyelid surgery training; awards recognize innovation in medical training and leadership in ESG best practices.
Stratasys (Nasdaq: SSYS) will release first quarter 2026 financial results for the period ended March 31, 2026, on Thursday, May 7, 2026, and will host a conference call the same day at 8:30 a.m. ET.
Investors can join via live webcast at investors.stratasys.com or the provided webcast link, or by telephone (U.S. toll-free 877-407-0619; international +1-412-902-1012). The webcast will be available for six months.
Stratasys (NASDAQ: SSYS) unveiled platform, software and materials updates to accelerate industrial and medical additive manufacturing. Key launches include the J850 Core PolyJet system (bookings open end of April), the biocompatible P3 MED Silicone 25A for Origin printers (ISO 10993), a 10‑app Additive App Suite for GrabCAD, and SAF PA12 powered by Evonik with up to 14% lower total cost of ownership.
The releases target faster iteration, scalable low‑volume medical parts, embedded design automation, and lower operating costs for industrial 3D production.
Stratasys (NASDAQ: SSYS) unveiled new materials, software and platform updates on April 7, 2026 to broaden additive manufacturing applications across FDM, PolyJet, P3 DLP, and SLA technologies. Key additions include ULTEM 1010 filament for F3300, PolyJet ToughONE for J3/J5, GrabCAD Print Pro Measurement‑Based Warped Modeling, and Somos WaterShed White for Neo printers.
Updates target higher‑temperature, production‑grade parts, improved dimensional accuracy, and longer uninterrupted runs for industrial users, with demos at RAPID + TCT (Apr 14–16) booth #1601.
Stratasys (NASDAQ: SSYS) said Stratasys Direct was selected for the U.S. Department of War Joint Additive Manufacturing Acceptability (JAMA) IV Pilot Parts Program, a multimillion-dollar effort to speed qualification and fielding of 3D-printed parts for military platforms.
DoW additive manufacturing funding rose 83% to $3.3 billion for fiscal 2026 versus 2025. Stratasys cited double-digit 2025 aerospace and defense revenue growth, >100,000 parts shipped annually, and a cited $14 million annual fuel savings from C-17 microvanes.
Stratasys (NASDAQ: SSYS) announced that its TrueDent® resins received CE Class IIa certification in Europe on March 17, 2026, qualifying as the first high‑esthetic, monolithic 3D‑printed denture solution in the >$2 billion European market.
The approval expands indications to long‑term intraoral removables (>30 days), crowns and bridges, enables broader clinical use, and requires no changes to existing J5 DentaJet printer workflows via a defined conversion kit.
Stratasys (Nasdaq: SSYS) filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the SEC on March 5, 2026. The filing includes the company’s audited 2025 financial statements and is available on the SEC website and the company investor site.
Shareholders can request a free hard copy by contacting Yonah Lloyd, Chief Communications Officer and VP Investor Relations, at Yonah.Lloyd@stratasys.com. Stratasys may use social media to share material non-public information per Regulation FD and will include required disclosures in public filings where mandated.
Stratasys (Nasdaq: SSYS) reported fourth-quarter 2025 revenue of $140.0M and GAAP net loss of $18.9M (Q4). For full year 2025, revenue was $551.1M, GAAP net loss $104.3M, and non-GAAP net income rose to $12.7M. Adjusted EBITDA grew to $28.5M and operating cash flow was $15.1M. Year-end cash and equivalents were $244.5M with no debt. The company provided 2026 guidance: revenue $565M–$575M, non-GAAP net income $8M–$12.5M, and Adjusted EBITDA $25M–$30M, assuming ~$17M adverse FX/tariff impact.